- illustrations
- A Focal Adenomyoma Within the Uterine Myometrium
A Focal Adenomyoma Within the Uterine Myometrium
A focal adenomyoma within the uterine myometrium, presenting as a localized nodule within the muscular wall.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Centered on the uterus, the animation tracks a focal adenomyoma embedded within the myometrium, the thick smooth-muscle layer between endometrium internally and serosa (perimetrium) externally. As the sequence progresses, the localized nodule is shown as a well-circumscribed area within the muscular wall rather than a pedunculated mass, with its margins expanding and contracting subtly against surrounding myometrial bundles. A gentle sectional sweep clarifies depth, keeping the lesion intramural and separate from the endometrial cavity while remaining closer to it than to the uterine serosal surface. Clinically, adenomyoma represents a focal form of adenomyosis, ectopic endometrial glands and stroma with reactive myometrial hypertrophy, and it often enters the differential for abnormal uterine bleeding, dysmenorrhea, and subfertility. The animated build-up helps distinguish an intramural adenomyomatous nodule from a leiomyoma by emphasizing its relationship to the endometrium and the way it blends with adjacent myometrium rather than creating a sharply compressive interface. That distinction matters in ultrasound and MRI correlation, and in planning hysteroscopic versus laparoscopic approaches when symptoms persist despite medical therapy. Use it in gynecologic pathology and reproductive anatomy teaching to anchor the concept of adenomyosis as a spectrum, from diffuse thickening to a focal adenomyoma. It also fits well in patient-facing counseling modules, radiology-pathology conference decks, and medical publisher content discussing causes of heavy menstrual bleeding and uterine-sparing treatment options. Anatomical accuracy verified by SciePro's Medical Advisory Board.